On the other hand, FSTL3 overexpression in CRC cells that are depleted for β-Catenin, were not able to show up an increase expression of these rate-limiting metabolic enzymes, suggesting that the here presented effects largely depend on active β-Catenin. The gene discussed is FSTL3; the disease is colorectal carcinoma.